ResMed (RMD) Tops Q1 EPS by 3c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $190.57 +1.12%
Revenue Growth %: +13.1%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +13.1%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $2.55, $0.03 better than the analyst estimate of $2.52. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.33 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
